NASDAQ: POETPoet Technologies Inc Stock
$2.23+0.08 (+3.72%)
Updated May 10, 2024
POET Price
$2.23
Fair Value Price
-$0.27
Market Cap
$94.75M
52 Week Low
$0.72
52 Week High
$5.88
P/E
-4.37x
P/B
19.21x
P/S
81.69x
PEG
N/A
Dividend Yield
N/A
Revenue
$465.78k
Earnings
-$20.27M
Gross Margin
100%
Operating Margin
-4,336.23%
Profit Margin
-4,351.3%
Debt to Equity
0.78
Operating Cash Flow
-$15M
Beta
0.88
Next Earnings
Jun 21, 2024
Ex-Dividend
N/A
Next Dividend
N/A
POET Overview
POET Technologies Inc. manufactures discrete and integrated opto-electronic solutions in the U.S., Canada, and Singapore. The company offerings are based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques and packaging methods. The company serves the data center, telecommunications, IoT and industrial sensing, automotive LIDAR, optical coherence tomography for medical devices, and virtual reality systems markets. POET Technologies was incorporated in 1972 and is headquartered in Toronto, Ontario, Canada.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how POET scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
POET ($2.23) is overvalued by 930.68% relative to our estimate of its Fair Value price of -$0.27 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
POET ($2.23) is not significantly undervalued (930.68%) relative to our estimate of its Fair Value price of -$0.27 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
POET is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more POET due diligence checks available for Premium users.
Be the first to know about important POET news, forecast changes, insider trades & much more!
POET News
Valuation
POET fair value
Fair Value of POET stock based on Discounted Cash Flow (DCF)
Price
$2.23
Fair Value
-$0.27
Undervalued by
930.68%
POET ($2.23) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
POET ($2.23) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
POET is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
POET price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.37x
Industry
64.08x
Market
30.02x
POET price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
19.21x
Industry
8.15x
POET is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
POET's financial health
Profit margin
Revenue
$107.6k
Net Income
-$5.5M
Profit Margin
-5,086.9%
POET's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
POET's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.8M
Liabilities
$3.8M
Debt to equity
0.78
POET's short-term assets ($3.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
POET's short-term assets ($3.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
POET's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
POET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.9M
Investing
-$35.4k
Financing
$1.3M
POET's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
POET vs Semiconductor Stocks
Poet Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.